Page last updated: 2024-11-04

vorinostat and Intestinal Perforation

vorinostat has been researched along with Intestinal Perforation in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Intestinal Perforation: Opening or penetration through the wall of the INTESTINES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rettenmaier, MA1
Wong, H1
Stone, MK1
Bechtol, K1
Goldstein, BH1

Other Studies

1 other study available for vorinostat and Intestinal Perforation

ArticleYear
Vorinostat is a potential precipitant for severe gastrointestinal toxicity.
    The American surgeon, 2013, Volume: 79, Issue:11

    Topics: Antineoplastic Agents; Enterostomy; Female; Humans; Hydroxamic Acids; Intestinal Perforation; Middle

2013